FDA Says U.S. Approved India Psychotropic Drug Maker Has Dirty Lab
The FDA is returning to a normal overseas inspection workload. What they are finding is not pretty.
FDA Says U.S. Approved India Psychotropic Drug Maker Has Dirty Lab
FDA Again Allows Unapproved Chinese Chemotherapy Drugs into the U.S.
Generic Drugs Maker Intas Pharmaceuticals Keeps Failing Inspections
At India Drug Maker Aurobindo Lab, FDA Finds “Deficient” Manufacturing Equipment
FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US
Notorious India Drug Maker Intas Pharmaceuticals Gets FDA Import Alert, But Allowed to Export to US
FDA Considers Allowing Cancer Drug Imports from Unapproved Foreign Manufacturers
India-Based Contract Drug Manufacturer Astral SteriTech Recalls Medications